EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will report third-quarter financial results before U.S. markets open Thursday, October 29, giving investors an updated view of the injectable drug packaging and delivery manufacturer’s performance and business outlook.
The Exton-based company scheduled a conference call for 8:00 a.m. Eastern Time that day to discuss its quarterly results and expectations for the business.
West generated $3.07 billion in net sales during fiscal 2025 and operates a global manufacturing network serving pharmaceutical developers and drug manufacturers.
The company employs more than 10,000 people across 50 locations, including 26 manufacturing facilities worldwide. Its operations support the annual delivery of more than 41 billion pharmaceutical components and devices.
West supplies products used to contain and administer injectable medicines, making its financial performance relevant to pharmaceutical manufacturing and drug delivery supply chains.
Investors will be able to access the earnings webcast and accompanying presentation through the investor relations section of West’s corporate website.
Participants seeking to ask questions during the conference call must register in advance to receive telephone access information and a unique identification number.
A replay of the webcast will remain available on the company’s website for approximately 90 days after the call.
West is listed on the New York Stock Exchange under the ticker WST and is a constituent of the S&P 500 index.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.